These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8256707)

  • 1. Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE Study). Cardiac Arrest in Seattle: Conventional Amiodarone Drug Evaluation.
    Maynard C
    Am J Cardiol; 1993 Dec; 72(17):1295-300. PubMed ID: 8256707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
    Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation.
    Dolack GL
    Am J Cardiol; 1994 Feb; 73(4):237-41. PubMed ID: 8296753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators.
    Greene HL
    Am J Cardiol; 1993 Nov; 72(16):70F-74F. PubMed ID: 8237833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).
    Am J Cardiol; 1991 Mar; 67(7):578-84. PubMed ID: 2000790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
    N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
    Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A
    N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study.
    Tagami T; Matsui H; Tanaka C; Kaneko J; Kuno M; Ishinokami S; Unemoto K; Fushimi K; Yasunaga H
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):485-491. PubMed ID: 27618826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
    Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
    N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest.
    Tagami T; Matsui H; Ishinokami S; Oyanagi M; Kitahashi A; Fukuda R; Unemoto K; Fushimi K; Yasunaga H
    Resuscitation; 2016 Dec; 109():127-132. PubMed ID: 27568110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.